Grantee Name:
Dr. Giuseppe Viale
Organization:
International Breast Cancer Study Group
Country: European (Located in Switzerland)
Project Name:
Central Pathology Review of FFPE tumor blocks within the POSITIVE study
Funding Year:
2020
Project period: 5 years
Central Pathology Review of FFPE tumor blocks within the POSITIVE study
The primary goal of the POSITIVE trial is to determine if a two-year interruption of endocrine therapy results in a significantly higher breast cancer event rate in comparison to a historically estimated control rate if no interruption occurred. Samples have been collected from 90 % of the patients enrolled in the POSITIVE clinical trial and funding is required for processing and analysis.